Protara Therapeutics, Inc. (TARA)

3.62 +0.11 (+3.13%) USD  |  NASDAQ  |  Sep 22, 09:36
More

Protara Therapeutics CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for TARA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical CAPEX To Revenue (TTM) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2015 --
March 31, 2015 --
Date Value
December 31, 2014 --

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
NovelStem International Corp. --
Brainstorm Cell Therapeutics, Inc. --
Summit Therapeutics, Inc. --
Kezar Life Sciences, Inc. --
Clene, Inc. Upgrade